Trials / Completed
CompletedNCT04045652
Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women
Modifiable Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 223 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This study will utilize a longitudinal study design to better understand the natural history of oncogenic Human Papillomavirus (HPV) infections in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected Kenyan women, including the potentially modifiable (and non-modifiable) factors that are associated with progression of oncogenic HPV infection to clinical disease, including cervical cancer.
Conditions
Timeline
- Start date
- 2015-09-21
- Primary completion
- 2020-11-05
- Completion
- 2020-11-05
- First posted
- 2019-08-05
- Last updated
- 2024-07-17
Locations
3 sites across 3 countries: United States, Kenya, Uganda
Source: ClinicalTrials.gov record NCT04045652. Inclusion in this directory is not an endorsement.